Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 926,916. The enterprise value is 1.77 million.
| Market Cap | 926,916 |
| Enterprise Value | 1.77M |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has decreased by -45.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | -45.33% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | n/a |
| Float | 7.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.56, with an EV/FCF ratio of -3.72.
| EV / Earnings | -9.41 |
| EV / Sales | 0.15 |
| EV / EBITDA | 6.56 |
| EV / EBIT | n/a |
| EV / FCF | -3.72 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.66 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | -0.90 |
| Interest Coverage | -5.65 |
Financial Efficiency
Return on equity (ROE) is -7.38% and return on invested capital (ROIC) is -2.94%.
| Return on Equity (ROE) | -7.38% |
| Return on Assets (ROA) | -1.50% |
| Return on Capital (ROIC) | -2.94% |
| Revenue Per Employee | 295,446 |
| Profits Per Employee | -4,698 |
| Employee Count | 40 |
| Asset Turnover | 2.45 |
| Inventory Turnover | 4.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -51.85% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 23.32 |
| Average Volume (20 Days) | 1,471 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 11.82 million and -187,917 in losses. Loss per share was -0.03.
| Revenue | 11.82M |
| Gross Profit | 5.06M |
| Operating Income | -115,784 |
| Pretax Income | -136,281 |
| Net Income | -187,917 |
| EBITDA | -70,171 |
| EBIT | -115,784 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 229,696 in cash and 425,967 in debt, giving a net cash position of -196,271 or -0.03 per share.
| Cash & Cash Equivalents | 229,696 |
| Total Debt | 425,967 |
| Net Cash | -196,271 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 1.78M |
| Book Value Per Share | 0.15 |
| Working Capital | 1.77M |
Cash Flow
In the last 12 months, operating cash flow was -453,480 and capital expenditures -21,957, giving a free cash flow of -475,437.
| Operating Cash Flow | -453,480 |
| Capital Expenditures | -21,957 |
| Free Cash Flow | -475,437 |
| FCF Per Share | -0.06 |
Margins
Gross margin is 42.84%, with operating and profit margins of -0.98% and -1.15%.
| Gross Margin | 42.84% |
| Operating Margin | -0.98% |
| Pretax Margin | -1.15% |
| Profit Margin | -1.15% |
| EBITDA Margin | -0.59% |
| EBIT Margin | -0.98% |
| FCF Margin | n/a |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 45.33% |
| Shareholder Yield | 45.33% |
| Earnings Yield | -20.31% |
| FCF Yield | -51.29% |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -17.16. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.16 |
| Piotroski F-Score | n/a |